Index of reports
> Cases with Pancytopenia (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Campath side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-23
Patient: 60 year old female
Reactions: Endophthalmitis, Bronchopulmonary Aspergillosis, Cerebral Artery Embolism, Fungal Endocarditis, Pancytopenia, Infection in AN Immunocompromised Host
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Mycophenolate Mofetil
Indication: Graft Versus Host Disease
Fludara
Indication: Chronic Lymphocytic Leukaemia
Campath
Indication: Chronic Lymphocytic Leukaemia
Possible Campath side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-06
Patient: 60 year old female
Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Corticosteroid NOS
Dosage: unk
Indication: Graft Versus Host Disease
Fludara
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Mycophenolate Mofetil
Dosage: unk
Indication: Graft Versus Host Disease
Campath
Dosage: unk
Indication: Chronic Lymphocytic Leukaemia
Possible Campath side effects in female
Reported by a lawyer from United States on 2012-07-20
Patient: female
Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, qmo
Indication: Multiple Myeloma
Campath
End date: 2004-09-27
Thalidomide
Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid
Possible Campath side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Protein-Losing Gastroenteropathy, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd, on first 3 days of each 28 day cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Cyclophosphamide
Dosage: 360 mg, qd on first 3 days of each 28 day cycle
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Fludara
Dosage: 57.6 mg, qd on first 3 days of each 28 day cycle
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Possible Campath side effects in female
Reported by a consumer/non-health professional from France on 2012-04-20
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Protein-Losing Gastroenteropathy, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd, on first 3 days of each 28 day cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Fludara
Dosage: 57.6 mg, qd on first 3 days of each 28 day cycle
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Cyclophosphamide
Dosage: 360 mg, qd on first 3 days of each 28 day cycle
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-10-01
End date: 2008-11-26
Possible Campath side effects in female
Reported by a lawyer from United States on 2012-04-18
Patient: female
Reactions: Abdominal Pain, Vulval Ulceration, Upper Limb Fracture, Face Oedema, Hypotension, Phlebolith, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Depression, Bone Disorder, Discomfort, Impaired Healing, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Pneumonia, Stomatitis, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Atelectasis, Confusional State, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Hallucination, Sinusitis, Venous Lake, Pain in JAW, RIB Fracture, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Rash, Osteolysis, Deformity, Facial Pain, Pulmonary Fibrosis, Mucosal Inflammation, Anxiety, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thalidomide
Campath
Dosage: unk
End date: 2004-09-27
Aredia
Dosage: unk ukn, qmo
Indication: Multiple Myeloma
Other drugs received by patient: Darvocet-N 50; Magnesium; Aspirin; Augmentin '125'; Revlimid; Ativan; Calcium Carbonate; Hydralazine HCL; Prednisone TAB; COD-Liver OIL; Tylenol (Caplet); Chemotherapeutics NOS; Procrit / 00909301 /; Solu-Medrol; Lovastatin; Acyclovir; Neurontin; Peridex; MS Contin; Multivite; Mevacor; Scopolamine
Possible Campath side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07
Patient: 60 year old male
Reactions: Graft Versus Host Disease, Tuberculosis, Pseudomembranous Colitis, Cytomegalovirus Infection, Epstein-Barr Viraemia, Pancytopenia, Lymphoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Dosage: 100 mg, qd
Indication: Immunosuppression
Myfortic
Indication: Immunosuppression
Certican
Dosage: 0.25 mg, bid
Administration route: Oral
Mabthera
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-07-01
End date: 2011-07-01
Mabthera
Dosage: unk
Neoral
Dosage: 160 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-03-01
End date: 2011-06-01
Prograf
Dosage: unk
Indication: Graft Versus Host Disease in Skin
Campath
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-07-29
End date: 2011-08-01
Campath
Dosage: unk
Start date: 2011-08-11
Certican
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-06-01
End date: 2011-08-01
Myfortic
Dosage: 750 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-01
End date: 2011-06-01
Possible Campath side effects in 64 year old male
Reported by a physician from Italy on 2012-01-03
Patient: 64 year old male
Reactions: Visceral Leishmaniasis, Pancytopenia, Pyrexia, Splenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate
Possible Campath side effects in male
Reported by a individual with unspecified qualification from United States on 2011-12-05
Patient: male, weighing 61.0 kg (134.3 pounds)
Reactions: Productive Cough, Biopsy Lung Abnormal, Rales, Cardiomegaly, Pericardial Effusion, Oedema Peripheral, Pneumothorax, Cardiac Failure Congestive, Pulmonary Necrosis, Cytomegalovirus Test Positive, Anaemia, Pancytopenia, Fungal Infection, Rhonchi, Dehydration, non-Small Cell Lung Cancer, Confusional State, Atelectasis, Nuchal Rigidity, Fall, Fatigue, Musculoskeletal Stiffness, Pleural Effusion, Abdominal Distension, Sinusitis, Thrombocytopenia, Decreased Appetite, Lethargy, Candidiasis, Dyspnoea, Lung Neoplasm, Jugular Vein Distension, Cerebral Atrophy, Ascites, Disease Recurrence, Hypophagia, Aspergillosis, Bronchitis, Gait Disturbance, Asthenia, Face Injury
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1212 mg
Pentostatin
Dosage: 8 mg
Campath
Dosage: 60 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 758 mg
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-30
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen
|